Current challenges for drug substance CDMOs in the Oligonucleotide space
30 Oct 2024
Manufacturing
![Current challenges for drug substance CDMOs in the Oligonucleotide space](https://cdn.asp.events/CLIENT_HubXchan_638DBA0F_0C6E_8D3C_A444829FC0C4B73E/sites/HubXChange/media/PolyPeptide.png/fit-in/1500x9999/filters:no_upscale())
- What are the timeline and scale expectations?
- What is important when selecting your CMO?
- How important is innovation and the move towards greener processes?